ISAM-CG557
ISAM-CG557 is a selective CB2R agonist, with a Ki of 54.6 nM. ISAM-CG557 reduces intracellular ROS levels and caspase activity. ISAM-CG557 exhibits significant MAPK bias and moderate G-protein bias, with CB2R EC50s of 0.60 nM (cAMP), 60.9 nM (β-arrestin) and 0.03 nM (MAPK) . ISAM-CG557 exerts potent anti-inflammatory effects by reducing pro-inflammatory cytokines and increasing anti-inflammatory cytokines in cells. ISAM-CG557 can be used for the study of neuroinflammatory and neurodegenerative disorders[1].
Product Specifications
UNSPSC
12352100
Target
Arrestin; Cannabinoid Receptor; Caspase; p38 MAPK; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; GPCR/G Protein; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
O=C([C@H]1N(C(C2=NN(CC3=CC=C(F)C=C3)C4=C2C=CC=C4)=O)CCCC1)N
Molecular Formula
C21H21FN4O2
Molecular Weight
380.42
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Coenzyme A S-Pyrazinecarboxylate Trisodium Salt
Recombinant Phospho-Tau (Thr217) Monoclonal Antibody
Recombinant Phospho-Tau (Thr217) Monoclonal Antibody
